Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 7, pp. 4514-4540
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Update and latest advances in antiretroviral therapy
Luis Menéndez‐Arias, Rafaël Delgado
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 16-29
Open Access | Times Cited: 139
Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges
Shaoqing Du, Xueping Hu, Luis Menéndez‐Arias, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101053-101053
Closed Access | Times Cited: 14
Modular Construction of Multivariate Metal–Organic Frameworks for Luminescent Sensing
Zongsu Han, Kunyu Wang, Rong‐Ran Liang, et al.
Journal of the American Chemical Society (2025)
Open Access | Times Cited: 1
Approved HIV reverse transcriptase inhibitors in the past decade
Guangdi Li, Yali Wang, Erik De Clercq
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1567-1590
Open Access | Times Cited: 74
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3729-3757
Open Access | Times Cited: 50
4′-Modified Nucleosides for Antiviral Drug Discovery: Achievements and Perspectives
Junbiao Chang
Accounts of Chemical Research (2022) Vol. 55, Iss. 4, pp. 565-578
Closed Access | Times Cited: 48
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
Ikbel Hadj Hassine, Manel Ben M’hadheb-Gharbi, Luis Menéndez‐Arias
Viruses (2022) Vol. 14, Iss. 4, pp. 841-841
Open Access | Times Cited: 42
Recent Advances in PROTAC-Based Antiviral Strategies
Haleema Ahmad, Bushra Zia, Hashir Husain, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 270-270
Open Access | Times Cited: 27
Recent advances in targeted protein degraders as potential therapeutic agents
Na Yang, Bo Kong, Zhaohong Zhu, et al.
Molecular Diversity (2023) Vol. 28, Iss. 1, pp. 309-333
Open Access | Times Cited: 21
An Overview of the Recent Advances in Antimicrobial Resistance
Manuela Oliveira, Wilson Antunes, Salete Mota, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1920-1920
Open Access | Times Cited: 13
Decoding molnupiravir-induced mutagenesis in SARS-CoV-2
Luis Menéndez‐Arias
Journal of Biological Chemistry (2021) Vol. 297, Iss. 1, pp. 100867-100867
Open Access | Times Cited: 51
Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1702-1714
Open Access | Times Cited: 42
Different Aspects of Emetine’s Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19
Mehdi Valipour
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 6, pp. 387-399
Open Access | Times Cited: 27
Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
Letian Song, Shenghua Gao, Bing Ye, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 87-109
Open Access | Times Cited: 19
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
The role of ferroptosis in metabolic diseases
Ling Xie, Bin Fang, Chun Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 6, pp. 119480-119480
Open Access | Times Cited: 16
Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new areas and new paradigms for antiviral drug research
Shaoqing Du, Xueping Hu, Xinyong Liu, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103888-103888
Closed Access | Times Cited: 5
Therapeutic cysteine protease inhibitors: a patent review (2018–present)
Giulia Barchielli, Antonella Capperucci, Damiano Tanini
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 17-49
Open Access | Times Cited: 5
Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
Priyanka Chambial, Neelam Thakur, Prudhvi Lal Bhukya, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 3
Closed Access
Phytomedical Properties of Carica papaya for Boosting Human Immunity Against Viral Infections
Rashmi Srivastava, Neeshma Jaiswal, Harsha Kharkwal, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 271-271
Open Access
Commercialization of endophytic fungus–derived therapeutics: Opportunities and challenges
Mukhtar Lawal Abubakar, Neha Kapoor, Asha Sharma, et al.
Elsevier eBooks (2025), pp. 233-250
Closed Access
Structure-based Design of Novel 2,4,5-Trisubstituted Pyrimidine Derivatives as Potent HIV-1 NNRTIs by Exploiting the Tolerant Regions in NNTRIs Binding Pocket
Zhenzhen Zhou, Minghui Xie, Zongji Zhuo, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117464-117464
Closed Access
Biosafety chemistry and biosafety materials: A new perspective to solve biosafety problems
Yingjie Yu, Jianxun Ding, Yunhao Zhou, et al.
Biosafety and Health (2022) Vol. 4, Iss. 1, pp. 15-22
Open Access | Times Cited: 26
Recent advances of novel fourth generation EGFR inhibitors in overcoming C797S mutation of lung cancer therapy
Li Xu, Bing Xu, Jianshe Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114900-114900
Closed Access | Times Cited: 26
Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
Shujing Xu, Dang Ding, Xujie Zhang, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 850-850
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top